Open AccessCell‐mediated autoimmunity in patients with Wegener's granulomatosis (WG)
Author(s) -
BALLIEUX B. E. P. B.,
BURG S. H.,
HAGEN E. C.,
WOUDE F. J.,
MELIEF C. J. M.,
DAHA M. R.
Publication year - 1995
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.1995.tb03651.x
Subject(s) - azurophilic granule , immunology , proteinase 3 , biology , epitope , t cell , cytolysis , hla dr , immune system , microbiology and biotechnology , antigen , cytotoxic t cell , in vitro , inflammation , autoantibody , antibody , biochemistry , myeloperoxidase
SUMMARY Despite the well described infiltration of cells of the cellular immune system in vasculitic lesions and the granuloma formation in patients with WG, the role of T cell‐mediated autoimmunity in WG is not clear. Reports of T cell proliferation in response to neutrophil azurophilic granule proteins are contradictory. In this study we have assessed the proliferation of T cells of WG patients to purified proteinase 3 (PR3) and to total azurophilic granule proteins in two different assays. In addition to the classical proliferation assay with isolated peripheral blood mononuclear cells, we have used a whole blood proliferation assay. In both assays we found proliferative responses to PR3 in patients with WG. The number of patients reacting to the azurophilic granule extract was higher than the patients reacting to the purified PR3, suggesting that other autoantigens may also be involved. We have identified epitopes of PR3 that may be potential targets of class I‐restricted T cell responses in the context of HLA‐A*0201, the most common MHC class I molecule. These epitopes were determined by the binding of synthetic PR3 peptides to HLA‐A*0201 on the antigen‐processing defective cell line, T2. In addition, T cell lines were established from tissue biopsies, obtained from WG patients, and assessed for cytolytic reactivity against T2 cells, preloaded with synthetic PR3 peptides. We conclude that T lymphocytes of WG patients have increased proliferative responses to purified PR3 and to a larger extent to non‐fractionated proteins of azurophilic granules of polymorphonuclear neutrophilic leucocytes (PMN).